Federal Autism Panel’s Push for "Profound Autism" Label Sparks Controversy Amidst Procedural Concerns
A significant shift within a key federal autism advisory panel, orchestrated by U.S. Secretary of Health and Human Services Robert…
push
FDA Withdraws Approval of Wellcovorin, a Branded Version of Leucovorin, Ending Controversial Autism Treatment Push
The U.S. Food and Drug Administration (FDA) has officially withdrawn its approval for Wellcovorin, the branded formulation of leucovorin, marking…
